HB 1439

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control.

In committee Last action May 12, 2025: Referred to Health

Official bill page and text: palegis.us

Sponsors 19

Prime sponsor: Jennifer O'Mara
Cosponsors (18): Benjamin Sanchez, Carol Hill-Evans, Christopher Rabb, Craig Williams, Danilo Burgos, Jose Giral, Joseph Hohenstein, Lisa Borowski, Mandy Steele, Mark Gillen, Maureen Madden, Melissa Cerrato, Michael Schlossberg, Michael Stender, Nikki Rivera, Paul Takac, R. Lee James, Tarik Khan

Status

In committee as of May 12, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
May 12, 2025	House	Referred to Health

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.